ELOX logo

Eloxx Pharmaceuticals (ELOX) Long Term Liabilities

Annual Total Long Term Liabilities

$8.69 M
-$4.11 M-32.09%

December 31, 2022


Summary


Performance

ELOX Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXbalance sheetmetrics:

Quarterly Long Term Liabilities

$2.62 M
-$714.00 K-21.39%

September 30, 2023


Summary


Performance

ELOX Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

ELOX Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-32.1%-74.2%
3 y3 years-20.4%-66.7%
5 y5 years+100.0%+100.0%

ELOX Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-32.1%at low-79.5%at low
5 y5-year-32.1%+35.6%-79.6%at low
alltimeall time-32.1%-100.0%-81.3%-100.0%

Eloxx Pharmaceuticals Long Term Liabilities History

DateAnnualQuarterly
Sep 2023
-
$2.62 M(-21.4%)
Jun 2023
-
$3.34 M(-17.2%)
Mar 2023
-
$4.03 M(-53.6%)
Dec 2022
$8.69 M(-32.1%)
$8.69 M(-14.6%)
Sep 2022
-
$10.18 M(-12.4%)
Jun 2022
-
$11.63 M(-8.9%)
Mar 2022
-
$12.76 M(-0.3%)
Dec 2021
$12.80 M(+99.7%)
$12.80 M(-0.6%)
Sep 2021
-
$12.88 M(+170.7%)
Jun 2021
-
$4.76 M(-3.4%)
Mar 2021
-
$4.92 M(-23.2%)
Dec 2020
$6.41 M(-41.3%)
$6.41 M(-18.7%)
Sep 2020
-
$7.88 M(-11.1%)
Jun 2020
-
$8.86 M(-8.7%)
Mar 2020
-
$9.70 M(-11.2%)
Dec 2019
$10.93 M(>+9900.0%)
$10.93 M(-5.8%)
Sep 2019
-
$11.60 M(-9.5%)
Jun 2019
-
$12.82 M(-8.6%)
Mar 2019
-
$14.03 M(>+9900.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(-100.0%)
Jun 2018
-
$91.00 K(>+9900.0%)
Mar 2018
-
$0.00(-100.0%)
Dec 2017
$0.00(-100.0%)
-
Sep 2017
-
$2.20 M(0.0%)
Jun 2017
-
$2.20 M(0.0%)
Jun 2017
$2.20 M(-48.8%)
-
Mar 2017
-
$2.20 M(0.0%)
Dec 2016
-
$2.20 M(-24.6%)
Sep 2016
-
$2.92 M(-32.0%)
Jun 2016
$4.30 M(-34.3%)
$4.30 M(-5.4%)
Mar 2016
-
$4.54 M(-28.5%)
Dec 2015
-
$6.35 M(+1.5%)
Sep 2015
-
$6.26 M(-4.4%)
Jun 2015
$6.54 M(+62.8%)
$6.54 M(+61.3%)
Mar 2015
-
$4.06 M(-0.2%)
Dec 2014
-
$4.07 M(+1.1%)
Sep 2014
-
$4.02 M(0.0%)
Jun 2014
$4.02 M(+3931.8%)
$4.02 M(+3931.8%)
Mar 2014
-
$99.70 K(0.0%)
Dec 2013
-
$99.70 K(0.0%)
Sep 2013
-
$99.70 K(0.0%)
Jun 2013
$99.70 K(-70.5%)
$99.70 K(-72.4%)
Mar 2013
-
$361.50 K(+178.1%)
Dec 2012
-
$130.00 K(-33.2%)
Sep 2012
-
$194.50 K(-42.5%)
Jun 2012
$338.50 K
$338.50 K(-32.7%)
Mar 2012
-
$502.60 K(-13.2%)
Dec 2011
-
$578.70 K(+7.3%)
DateAnnualQuarterly
Sep 2011
-
$539.30 K(-33.5%)
Jun 2011
$811.00 K(-68.8%)
$811.00 K(-16.1%)
Mar 2011
-
$967.00 K(-3.5%)
Dec 2010
-
$1.00 M(-23.3%)
Sep 2010
-
$1.31 M(-49.8%)
Jun 2010
$2.60 M(+2032.5%)
$2.60 M(+73.7%)
Mar 2010
-
$1.50 M(+54.0%)
Dec 2009
-
$972.50 K(-32.6%)
Sep 2009
-
$1.44 M(+1083.5%)
Jun 2009
$122.00 K(-0.7%)
$122.00 K(+2.2%)
Mar 2009
-
$119.40 K(-0.4%)
Dec 2008
-
$119.90 K(-1.1%)
Sep 2008
-
$121.20 K(-1.3%)
Jun 2008
$122.80 K(-4.7%)
$122.80 K(-87.0%)
Mar 2008
-
$943.80 K(+146.2%)
Dec 2007
-
$383.40 K(+173.7%)
Sep 2007
-
$140.10 K(+8.7%)
Jun 2007
$128.90 K(-3.9%)
$128.90 K(-1.0%)
Mar 2007
-
$130.20 K(-1.0%)
Dec 2006
-
$131.50 K(-1.0%)
Sep 2006
-
$132.80 K(-1.0%)
Jun 2006
$134.10 K(+45.0%)
$134.10 K(+6.3%)
Mar 2006
-
$126.10 K(+16.2%)
Dec 2005
-
$108.50 K(+8.0%)
Sep 2005
-
$100.50 K(+8.6%)
Jun 2005
$92.50 K(+2.7%)
$92.50 K(+2.7%)
Mar 2005
-
$90.10 K(0.0%)
Dec 2004
-
$90.10 K(0.0%)
Sep 2004
-
$90.10 K(0.0%)
Jun 2004
$90.10 K(0.0%)
$90.10 K(0.0%)
Mar 2004
-
$90.10 K(0.0%)
Dec 2003
-
$90.10 K(0.0%)
Sep 2003
-
$90.10 K(0.0%)
Jun 2003
$90.10 K(+32.5%)
$90.10 K(0.0%)
Mar 2003
-
$90.10 K(+13.9%)
Dec 2002
-
$79.10 K(0.0%)
Sep 2002
-
$79.10 K(+16.3%)
Jun 2002
$68.00 K(+48.5%)
$68.00 K(+19.5%)
Mar 2002
-
$56.90 K(0.0%)
Dec 2001
-
$56.90 K(+24.2%)
Sep 2001
-
$45.80 K(0.0%)
Jun 2001
$45.80 K(>+9900.0%)
$45.80 K(0.0%)
Mar 2001
-
$45.80 K(+332.1%)
Dec 2000
-
$10.60 K(0.0%)
Sep 2000
-
$10.60 K(0.0%)
Mar 2000
-
$10.60 K
Jun 1999
$0.00(0.0%)
-
Jun 1998
$0.00(0.0%)
-
Jun 1997
$0.00
-

FAQ

  • What is Eloxx Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals annual total long term liabilities year-on-year change?
  • What is Eloxx Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals quarterly long term liabilities year-on-year change?

What is Eloxx Pharmaceuticals annual total long term liabilities?

The current annual total long term liabilities of ELOX is $8.69 M

What is the all time high annual total long term liabilities for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high annual total long term liabilities is $12.80 M

What is Eloxx Pharmaceuticals annual total long term liabilities year-on-year change?

Over the past year, ELOX annual total long term liabilities has changed by -$4.11 M (-32.09%)

What is Eloxx Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of ELOX is $2.62 M

What is the all time high quarterly long term liabilities for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high quarterly total long term liabilities is $14.03 M

What is Eloxx Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, ELOX quarterly total long term liabilities has changed by -$7.56 M (-74.23%)